{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T04:43:30Z","timestamp":1790484210435,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2009,9,4]],"date-time":"2009-09-04T00:00:00Z","timestamp":1252022400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00259-009-1254-2","type":"journal-article","created":{"date-parts":[[2009,9,3]],"date-time":"2009-09-03T11:41:53Z","timestamp":1251978113000},"page":"242-249","source":"Crossref","is-referenced-by-count":20,"title":["Recombinant human TSH and ablation of post-surgical thyroid remnants in differentiated thyroid cancer: the effect of pre-treatment with furosemide and furosemide plus lithium"],"prefix":"10.1007","volume":"37","author":[{"given":"Daniele","family":"Barbaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Grosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Boni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Lapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Orsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Meucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Cristina","family":"Marzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Berti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliano","family":"Mariani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Rubello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2009,9,4]]},"reference":[{"issue":"4","key":"1254_CR1","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/jcem.86.4.7407","volume":"86","author":"EL Mazzaferri","year":"2001","unstructured":"Mazzaferri EL, Kloos RT. Current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86(4):1447\u201363.","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"1254_CR2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1089\/thy.2006.16.109","volume":"16","author":"DS Cooper","year":"2006","unstructured":"Cooper DS, Doherty GM, Haugen BR, Kloos RT, Lee SL, Mandel SJ, et al. The American Thyroid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16(2):109\u201342.","journal-title":"Thyroid"},{"key":"1254_CR3","first-page":"28S","volume":"46","author":"R Robbins","year":"2005","unstructured":"Robbins R, Schlumberger M. The evolving role of 131 I for the treatment of differentiated thyroid cancer. J Nucl Med. 2005;46:28S\u201337S.","journal-title":"J Nucl Med"},{"key":"1254_CR4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1089\/thy.1997.7.265","volume":"7","author":"EL Mazzaferri","year":"1997","unstructured":"Mazzaferri EL. Thyroid remnant 131-I ablation for papillary and follicular thyroid carcinoma. Thyroid. 1997;7:165\u2013271.","journal-title":"Thyroid"},{"key":"1254_CR5","doi-asserted-by":"crossref","first-page":"4195","DOI":"10.1210\/jcem.83.12.5293-1","volume":"83","author":"L Wartofsky","year":"1998","unstructured":"Wartofsky L, Sherman SI, Gopal J, Sclumberger M, Hay ID. The use of radioactive iodine in patients with papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 1998;83:4195\u20139.","journal-title":"J Clin Endocrinol Metab"},{"key":"1254_CR6","doi-asserted-by":"crossref","first-page":"3668","DOI":"10.1210\/jc.2003-031167","volume":"89","author":"AM Sawka","year":"2004","unstructured":"Sawka AM, Thephamongkhol K, Brouwers M, Thabane L, Browman G, Gerstein HC. A systemic review and meta-analysis of the effectiveness of radioactive iodine remnant ablation for well differentiated thyroid cancer. J Clin Endocrinol Metab. 2004;89:3668\u201376.","journal-title":"J Clin Endocrinol Metab"},{"key":"1254_CR7","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1210\/jcem.86.2.7189","volume":"86","author":"R Robbins","year":"2001","unstructured":"Robbins R, Tuttle M, Sharaf R. Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab. 2001;86:619\u201325.","journal-title":"J Clin Endocrinol Metab"},{"key":"1254_CR8","doi-asserted-by":"crossref","unstructured":"Luster M, Sherman SI, Skarulis MC, Reynolds JR, Lassmann M, Hanscheid, et al. Comparison of radioiodine biokinetics following the administration of recombinant human thyroid stimulating hormone and after thyroid hormone withdrawal in thyroid carcinoma. Eur J Nucl Med Mol Imaging. 2003 Oct;30(10):1371\u20137.","DOI":"10.1007\/s00259-003-1230-1"},{"issue":"4","key":"1254_CR9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00259-006-0279-z","volume":"34","author":"P Canotti-Fregonara","year":"2007","unstructured":"Canotti-Fregonara P, Khory A, Duron F, Keller L, Christin-Maitre S, Kiffel T, et al. Which thyroid cancer patients need periodic stimulation tests? Eur J Nucl Med Mol Imaging. 2007;34(4):541\u20136.","journal-title":"Eur J Nucl Med Mol Imaging."},{"issue":"5","key":"1254_CR10","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2967\/jnumed.107.049072","volume":"49","author":"RM Tuttle","year":"2008","unstructured":"Tuttle RM, Brokhin M, Omry G, Martorella AJ, Larson SM, Grewal RK, et al. Recombinant human TSH-assisted radioactive iodine remnant ablation achieves short-term clinical recurrence rates similar to those of traditional thyroid hormone withdrawal. J Nucl Med. 2008;49(5):764\u201370.","journal-title":"J Nucl Med."},{"issue":"9","key":"1254_CR11","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1210\/jc.2003-030298","volume":"88","author":"D Barbaro","year":"2003","unstructured":"Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, et al. Radioiodine treatment with 30\u00a0mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness of postsurgical remnants ablation and possible role of iodine content in L-Thyroxine in the outcome of ablation. J Clin Endocrinol Metab. 2003;88(9):4110\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"9","key":"1254_CR12","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1089\/thy.2000.10.767","volume":"10","author":"EL Mazzaferri","year":"2000","unstructured":"Mazzaferri EL, Kloos RT. Using recombinant human TSH in the management of well-differentiated thyroid cancer: current strategies and future directions. Thyroid. 2000;10(9):767\u201378.","journal-title":"Thyroid."},{"issue":"9","key":"1254_CR13","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1210\/jc.2007-0225","volume":"92","author":"T Pilli","year":"2007","unstructured":"Pilli T, Brianzoni E, Capoccetti F, Castagna MG, Fattori S, Poggiu A, et al. A comparison of 1850 (50\u00a0mCi) and 3700\u00a0MBq (100\u00a0mCi) 131-iodine administered doses for recombinant thyrotropin-stimulated postoperative thyroid remnant ablation in differentiated thyroid cancer. J Clin Endocrinol Metab. 2007;92(9):3542\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"8","key":"1254_CR14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1097\/00006231-200608000-00005","volume":"27","author":"D Barbaro","year":"2006","unstructured":"Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P, et al. Recombinant human thyroid-stimulating hormone is effective for radioiodine ablation of post-surgical thyroid remnants. Nucl Med Com. 2006;27(8):627\u201332.","journal-title":"Nucl Med Com"},{"issue":"9","key":"1254_CR15","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1210\/jc.2001-011918","volume":"87","author":"F Pacini","year":"2002","unstructured":"Pacini F, Molinaro E, Castagna MG, Lippi F, Ceccarelli C, Agate L, et al. Ablation of thyroid residues with 30\u00a0mCi 131-I: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab. 2002;87(9):4063\u20138.","journal-title":"J Clin Endocrinol Metab"},{"key":"1254_CR16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1365-2265.2003.01735.x","volume":"58","author":"MJHM Pluijmen","year":"2003","unstructured":"Pluijmen MJHM, Eustatia-Rutten C, Goslings BM, Stokkel MP, Pereira Arias A, Diamant M, et al. Effects of low iodide diet on postsurgical radioiodide ablation therapy in patients with differentiated thyroid carcinoma. Clin Endocrinol. 2003;58:428\u201335.","journal-title":"Clin Endocrinol"},{"key":"1254_CR17","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1007\/s00259-003-1251-9","volume":"30","author":"LO Kapucu","year":"2003","unstructured":"Kapucu LO, Azizoglu F, Avvaz G, Karakoc A. Effects of diuretics on iodine uptake in non-toxic goitre: comparison with low-iodine diet. Eur J Nucl Med Mol Imaging. 2003;30:1270\u20132.","journal-title":"Eur J Nucl Med Mol Imaging."},{"key":"1254_CR18","first-page":"1065","volume":"44","author":"C Menzel","year":"2003","unstructured":"Menzel C, Kranert WT, Dobert N, Diehl M, Fietz T, Hamscho N, et al. RhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of 131-I. J Nucl Med. 2003;44:1065\u20138.","journal-title":"J Nucl Med"},{"issue":"8","key":"1254_CR19","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/10507250152484583","volume":"11","author":"LF Morris","year":"2001","unstructured":"Morris LF, Wilder MS, Waxman AD, Braunstein GD. Reevaluation of the impact of a stringent low-iodine diet on ablation rates in radioiodine treatment of thyroid carcinoma. Thyroid. 2001;11(8):749\u201355.","journal-title":"Thyroid"},{"issue":"10","key":"1254_CR20","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1089\/thy.1998.8.909","volume":"8","author":"JH Lazaurus","year":"1998","unstructured":"Lazaurus JH. The effects of lithium therapy on thyroid and thyrotropin-releasing hormone. Thyroid. 1998;8(10):909\u201313.","journal-title":"Thyroid"},{"issue":"3","key":"1254_CR21","first-page":"912","volume":"84","author":"SS Koong","year":"1999","unstructured":"Koong SS, Reynolds JC, Movius EG, Keenan AM, Ain KB, Lakshmanan MC, et al. Lithium as a potential adjuvant to 131-I therapy of metastatic, well-differentiated thyroid carcinoma. J Clin Endocrinol Metab. 1999;84(3):912\u20136.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"1254_CR22","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1111\/j.1365-2265.2006.02515.x","volume":"64","author":"YY Liu","year":"2006","unstructured":"Liu YY, van der pluijm G, Karperien M, Stokkel MP, Pereira AM, Morreau J, et al. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies. Clin Endocrinol (Oxf). 2006;64(6):617\u201324.","journal-title":"Clin Endocrinol (Oxf)"},{"issue":"6","key":"1254_CR23","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/00006231-200006000-00004","volume":"21","author":"JM Durki","year":"2000","unstructured":"Durki JM, Weigel RJ, McDougall IR. Recombinant human thyrotropin (rhTSH) in the management of differentiated thyroid cancer. Nucl Med Commun. 2000;21(6):521\u20138.","journal-title":"Nucl Med Commun"},{"issue":"5","key":"1254_CR24","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1089\/105072502760043486","volume":"12","author":"CS Bal","year":"2002","unstructured":"Bal CS, Kumar A, Pandey RM. A randomized controlled trial to evaluate the adjuvant effect of lithium on radioiodine treatment of hyperthyroidism. Thyroid. 2002;12(5):399\u2013405.","journal-title":"Thyroid"},{"issue":"5","key":"1254_CR25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1055\/s-0038-1625222","volume":"45","author":"S Dunkelmann","year":"2006","unstructured":"Dunkelmann S, Kunster H, Nabavi E, Eberlein U, Groth P, Schumichen C. Lithium as an adjunct to radioiodine therapy in Graves\u2019 disease for prolonging the intrathyroidal effective half-life of radioiodine. Useful or not? Nuklearmedizin. 2006;45(5):213\u20138.","journal-title":"Nuklearmedizin"},{"issue":"10","key":"1254_CR26","doi-asserted-by":"crossref","first-page":"4490","DOI":"10.1210\/jc.2002-020580","volume":"87","author":"F Bogazzi","year":"2002","unstructured":"Bogazzi F, Bartalena L, Campomori A, Brogioni S, Traino C, De Martino F, et al. Treatment with lithium prevents serum thyroid hormone increase after thionamide withdrawal and radioiodine therapy in patients with Grave\u2019s disease. J Clin Endocrinol Metab. 2002;87(10):4490\u20135.","journal-title":"J Clin Endocrinol Metab."},{"issue":"4","key":"1254_CR27","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1210\/endo.133.4.8404588","volume":"133","author":"MW Szkudlinski","year":"1993","unstructured":"Szkudlinski MW, Thotakura NR, Bucci I, Joshi LR, Tsai A, East-Palmer J, et al. Purification and characterization of recombinant human thyrotropin (TSH) isoforms produced by Chinese hamster ovary cells: the role of sialylation and sulfation in TSH bioactivity. Endocrinology. 1993;133(4):1490\u2013503.","journal-title":"Endocrinology"},{"issue":"5","key":"1254_CR28","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1089\/thy.1999.9.451","volume":"9","author":"J Robbins","year":"1999","unstructured":"Robbins J. Pharmacology of bovine and human thyrotropin: an historical perspective. Thyroid. 1999;9(5):451\u20133.","journal-title":"Thyroid"},{"issue":"1","key":"1254_CR29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1210\/endo-128-1-341","volume":"128","author":"NR Thotakura","year":"1991","unstructured":"Thotakura NR, Desai RK, Bates LG, Cole ES, Pratt MB, Weintraub BD. Biological activity and metabolic clearance of a recombinant human thyrotropin produced in Chinese hamster ovary cells. Endocrinology. 1991;128(1):67\u201381.","journal-title":"Endocrinology"},{"issue":"5","key":"1254_CR30","first-page":"1135","volume":"74","author":"LE Braverman","year":"1992","unstructured":"Braverman LE, Pratt MB, Ebner S, Longcope C. Recombinant human thyrotropin stimulates thyroid function and radioactive iodine uptake in the rhesus monkey. J Clin Endocrinol Metab. 1992;74(5):1135\u20139.","journal-title":"J Clin Endocrinol Metab"},{"issue":"4","key":"1254_CR31","first-page":"648","volume":"47","author":"H Hanscheid","year":"2006","unstructured":"Hanscheid H, Lassmann M, Luster M. Iodine biokinetics and dosimetry in radioiodine therapy of thyroid cancer: procedures and results of a prospective international controlled study of ablation after rhTSH or hormone withdrawal. J Nucl Med. 2006;47(4):648\u201354.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1254-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-009-1254-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-009-1254-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T12:01:49Z","timestamp":1558699309000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-009-1254-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9,4]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["1254"],"URL":"https:\/\/doi.org\/10.1007\/s00259-009-1254-2","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,9,4]]}}}